LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes.

    Liu, Jian / Guiadeen, Deodial / Krikorian, Arto / Gao, Xiaolei / Wang, James / Babu Boga, Sobhana / Alhassan, Abdul-Basit / Yu, Wensheng / Selyutin, Oleg / Yu, Younong / Anand, Rajan / Xu, Jiayi / Kelly, Joseph / Duffy, Joseph L / Liu, Shilan / Yang, Chundao / Wu, Hao / Cai, Jiaqiang / Bennett, Chad /
    Maloney, Kevin M / Tyagarajan, Sriram / Gao, Ying-Duo / Fischmann, Thierry O / Presland, Jeremy / Mansueto, My / Xu, Zangwei / Leccese, Erica / Zhang-Hoover, Jie / Knemeyer, Ian / Garlisi, Charles G / Stivers, Peter / Brandish, Philip E / Hicks, Alexandra / Kim, Ronald / Kozlowski, Joseph A

    Bioorganic & medicinal chemistry letters

    2020  Volume 30, Issue 17, Page(s) 127390

    Abstract: Bruton's tyrosine kinase (BTK) is a Tec family kinase with a well-defined role in the B cell receptor (BCR) pathway. It has become an attractive kinase target for selective B cell inhibition, and for the treatment of B cell related diseases. Many BTK ... ...

    Abstract Bruton's tyrosine kinase (BTK) is a Tec family kinase with a well-defined role in the B cell receptor (BCR) pathway. It has become an attractive kinase target for selective B cell inhibition, and for the treatment of B cell related diseases. Many BTK inhibitors have been discovered for the treatment of cancer and rheumatoid arthritis, including a series of BTK inhibitors based on 8-amino-imidazo[1,5-a]pyrazine we recently reported. The X-ray crystal structures of BTK with inhibitors were also published, which provided great help for the SAR design. Here we report our SAR work introducing ring constraints for the 3-position piperidine amides on the BTK inhibitors based on 8-amino-imidazo[1,5-a]pyrazine. This modification improved the potency in BTK inhibitions, as well as the PK profile and the off-target selectivity. The dose-dependent efficacy of two BTK inhibitors was observed in the rat collagen induced arthritis (CIA) model.
    MeSH term(s) Agammaglobulinaemia Tyrosine Kinase/antagonists & inhibitors ; Agammaglobulinaemia Tyrosine Kinase/metabolism ; Animals ; Arthritis, Experimental/drug therapy ; Binding Sites ; Bridged Bicyclo Compounds/chemistry ; Crystallography, X-Ray ; Disease Models, Animal ; Dogs ; Dose-Response Relationship, Drug ; Half-Life ; Humans ; Imidazoles/chemistry ; Imidazoles/metabolism ; Imidazoles/therapeutic use ; Molecular Dynamics Simulation ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/metabolism ; Protein Kinase Inhibitors/therapeutic use ; Pyrazines/chemistry ; Pyrazines/metabolism ; Pyrazines/therapeutic use ; Rats ; Rats, Wistar ; Structure-Activity Relationship ; src-Family Kinases/antagonists & inhibitors ; src-Family Kinases/metabolism
    Chemical Substances Bridged Bicyclo Compounds ; Imidazoles ; Protein Kinase Inhibitors ; Pyrazines ; imidazo(1,5-a)pyrazine ; Agammaglobulinaemia Tyrosine Kinase (EC 2.7.10.2) ; src-Family Kinases (EC 2.7.10.2)
    Language English
    Publishing date 2020-07-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2020.127390
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Discovery of novel BTK inhibitors with carboxylic acids.

    Gao, Xiaolei / Wang, James / Liu, Jian / Guiadeen, Deodial / Krikorian, Arto / Boga, Sobhana Babu / Alhassan, Abdul-Basit / Selyutin, Oleg / Yu, Wensheng / Yu, Younong / Anand, Rajan / Liu, Shilan / Yang, Chundao / Wu, Hao / Cai, Jiaqiang / Cooper, Alan / Zhu, Hugh / Maloney, Kevin / Gao, Ying-Duo /
    Fischmann, Thierry O / Presland, Jeremy / Mansueto, My / Xu, Zangwei / Leccese, Erica / Zhang-Hoover, Jie / Knemeyer, Ian / Garlisi, Charles G / Bays, Nathan / Stivers, Peter / Brandish, Philip E / Hicks, Alexandra / Kim, Ronald / Kozlowski, Joeseph A

    Bioorganic & medicinal chemistry letters

    2017  Volume 27, Issue 6, Page(s) 1471–1477

    Abstract: We report the design and synthesis of a series of novel Bruton's Tyrosine Kinase (BTK) inhibitors with a carboxylic acid moiety in the ribose pocket. This series of compounds has demonstrated much improved off-target selectivities including adenosine ... ...

    Abstract We report the design and synthesis of a series of novel Bruton's Tyrosine Kinase (BTK) inhibitors with a carboxylic acid moiety in the ribose pocket. This series of compounds has demonstrated much improved off-target selectivities including adenosine uptake (AdU) inhibition compared to the piperidine amide series. Optimization of the initial lead compound 4 based on BTK enzyme inhibition, and human peripheral blood mononuclear cell (hPBMC) and human whole blood (hWB) activity led to the discovery of compound 40, with potent BTK inhibition, reduced off target activities, as well as favorable pharmacokinetic profile in both rat and dog.
    MeSH term(s) Animals ; Carboxylic Acids/pharmacology ; Drug Discovery ; Humans ; Protein Kinase Inhibitors/pharmacology ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Rats
    Chemical Substances Carboxylic Acids ; Protein Kinase Inhibitors ; Agammaglobulinaemia tyrosine kinase (EC 2.7.10.1) ; Protein-Tyrosine Kinases (EC 2.7.10.1)
    Language English
    Publishing date 2017--15
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2016.11.079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis.

    Boga, Sobhana Babu / Alhassan, Abdul-Basit / Liu, Jian / Guiadeen, Deodial / Krikorian, Arto / Gao, Xiaolei / Wang, James / Yu, Younong / Anand, Rajan / Liu, Shilan / Yang, Chundao / Wu, Hao / Cai, Jiaqiang / Zhu, Hugh / Desai, Jagdish / Maloney, Kevin / Gao, Ying-Duo / Fischmann, Thierry O / Presland, Jeremy /
    Mansueto, My / Xu, Zangwei / Leccese, Erica / Knemeyer, Ian / Garlisi, Charles G / Bays, Nathan / Stivers, Peter / Brandish, Philip E / Hicks, Alexandra / Cooper, Alan / Kim, Ronald M / Kozlowski, Joseph A

    Bioorganic & medicinal chemistry letters

    2017  Volume 27, Issue 16, Page(s) 3939–3943

    Abstract: 8-Amino-imidazo[1,5-a]pyrazine-based Bruton's tyrosine kinase (BTK) inhibitors, such as 6, exhibited potent inhibition of BTK but required improvements in both kinase and hERG selectivity (Liu et al., 2016; Gao et al., 2017). In an effort to maintain the ...

    Abstract 8-Amino-imidazo[1,5-a]pyrazine-based Bruton's tyrosine kinase (BTK) inhibitors, such as 6, exhibited potent inhibition of BTK but required improvements in both kinase and hERG selectivity (Liu et al., 2016; Gao et al., 2017). In an effort to maintain the inhibitory activity of these analogs and improve their selectivity profiles, we carried out SAR exploration of groups at the 3-position of pyrazine compound 6. This effort led to the discovery of the morpholine group as an optimized pharmacophore. Compounds 13, 23 and 38 displayed excellent BTK potencies, kinase and hERG selectivities, and pharmacokinetic profiles.
    MeSH term(s) Arthritis, Rheumatoid/drug therapy ; Arthritis, Rheumatoid/metabolism ; Dose-Response Relationship, Drug ; Drug Discovery ; Humans ; Imidazoles/chemical synthesis ; Imidazoles/chemistry ; Imidazoles/pharmacology ; Leukocytes, Mononuclear/drug effects ; Leukocytes, Mononuclear/metabolism ; Models, Molecular ; Molecular Structure ; Morpholines/chemical synthesis ; Morpholines/chemistry ; Morpholines/pharmacology ; Protein Kinase Inhibitors/chemical synthesis ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/pharmacology ; Protein-Tyrosine Kinases/antagonists & inhibitors ; Protein-Tyrosine Kinases/metabolism ; Structure-Activity Relationship ; Transcriptional Regulator ERG/antagonists & inhibitors ; Transcriptional Regulator ERG/metabolism
    Chemical Substances 3-morpholino-imidazole(1,5-a)pyrazine ; ERG protein, human ; Imidazoles ; Morpholines ; Protein Kinase Inhibitors ; Transcriptional Regulator ERG ; Protein-Tyrosine Kinases (EC 2.7.10.1)
    Language English
    Publishing date 2017--15
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2017.03.040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis.

    Liu, Jian / Guiadeen, Deodial / Krikorian, Arto / Gao, Xiaolei / Wang, James / Boga, Sobhana Babu / Alhassan, Abdul-Basit / Yu, Younong / Vaccaro, Henry / Liu, Shilan / Yang, Chundao / Wu, Hao / Cooper, Alan / de Man, Jos / Kaptein, Allard / Maloney, Kevin / Hornak, Viktor / Gao, Ying-Duo / Fischmann, Thierry O /
    Raaijmakers, Hans / Vu-Pham, Diep / Presland, Jeremy / Mansueto, My / Xu, Zangwei / Leccese, Erica / Zhang-Hoover, Jie / Knemeyer, Ian / Garlisi, Charles G / Bays, Nathan / Stivers, Peter / Brandish, Philip E / Hicks, Alexandra / Kim, Ronald / Kozlowski, Joseph A

    ACS medicinal chemistry letters

    2015  Volume 7, Issue 2, Page(s) 198–203

    Abstract: Bruton's tyrosine kinase (BTK) is a Tec family kinase with a well-defined role in the B cell receptor (BCR) pathway. It has become an attractive kinase target for selective B cell inhibition and for the treatment of B cell related diseases. We report a ... ...

    Abstract Bruton's tyrosine kinase (BTK) is a Tec family kinase with a well-defined role in the B cell receptor (BCR) pathway. It has become an attractive kinase target for selective B cell inhibition and for the treatment of B cell related diseases. We report a series of compounds based on 8-amino-imidazo[1,5-a]pyrazine that are potent reversible BTK inhibitors with excellent kinase selectivity. Selectivity is achieved through specific interactions of the ligand with the kinase hinge and driven by aminopyridine hydrogen bondings with Ser538 and Asp539, and by hydrophobic interaction of trifluoropyridine in the back pocket. These interactions are evident in the X-ray crystal structure of the lead compounds 1 and 3 in the complex with the BTK enzyme. Our lead compounds show desirable PK profiles and efficacy in the preclinical rat collagen induced arthritis model.
    Language English
    Publishing date 2015-12-19
    Publishing country United States
    Document type Journal Article
    ISSN 1948-5875
    ISSN 1948-5875
    DOI 10.1021/acsmedchemlett.5b00463
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top